Final answer:
The program is known as iPLEDGE, a risk management system for prescribers and patients dealing with the acne medication isotretinoin, ensuring safety and compliance due to high potential risks.
Step-by-step explanation:
The program you’re referring to is known as iPLEDGE. It is a risk management program designed specifically for the prescription of isotretinoin, a medication used to treat severe acne that hasn’t responded to other treatments. Isotretinoin is known for its potential to cause serious birth defects, which is why the iPLEDGE program requires both prescribers and patients to be registered and follow strict guidelines. Prescribers must be certified with the program by completing training, and patients must meet all the requirements, which includes women of childbearing potential taking pregnancy tests and committing to using two forms of contraception.